Internal Medicine, Rheumatology · Cleveland, OH
NPI
1770503849
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
11100 Euclid Ave
Cleveland, OH, 44106
Phone (216) 844-8500
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
1,161 services
Medicare patients, 2024
367
Average age 73
Drug cost, 2024
$6.5M
6,542 prescriptions
Company payments, 2025
$2,142
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Van D Warren was code 99213 (office e&m - established), 229 times for 187 patients. In total Van D Warren billed 1,161 services in 13 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 229 | 187 | $59.33 | $14K |
| 99214 Office E&M - Established | Office | 199 | 153 | $85.41 | $17K |
| 99213 Office E&M - Established | Facility | 132 | 121 | $38.66 | $5,103 |
| 99214 Office E&M - Established | Facility | 91 | 80 | $55.24 | $5,027 |
By year: 2022 $44K for 872 services; 2023 $37K for 816 services; 2024 $46K for 1,161 services.
Medicare prescription drug claims, 2024
In 2024, the drug Van D Warren prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,021 prescriptions and refills. In total Van D Warren wrote 6,542 Medicare prescriptions that cost $6.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,021 | 2,050 | 223 | $31K |
| Prednisone Generic | 607 | 961 | 140 | $3,119 |
| Methotrexate Methotrexate Sodium | 450 | 916 | 111 | $9,621 |
| Gabapentin Generic | 391 | 653 | 87 | $7,126 |
| Leflunomide Generic | 298 | 633 | 75 | $12K |
| Allopurinol Generic | 251 | 568 | 62 | $1,504 |
| Duloxetine Hcl Generic | 224 | 340 | 52 | $4,289 |
| Tizanidine Hcl Generic | 198 | 259 | 34 | $2,280 |
| Alendronate Sodium Generic | 130 | 265 | 35 | $654 |
| Topiramate Generic | 125 | 237 | 31 | $1,671 |
| Enbrel Sureclick Etanercept | 122 | 135 | 20 | $996K |
| Humira(Cf) Pen Adalimumab | 111 | 112 | 13 | $1.1M |
| Sulfasalazine Generic | 109 | 193 | 25 | $1,739 |
| Benlysta Belimumab | 103 | 107 | 12 | $515K |
| Mycophenolate Mofetil Generic | 101 | 210 | 24 | $16K |
Brand drugs: 1,149 claims; generic drugs: 5,375 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Van D Warren $2,142 ($2,142 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $358.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 25 | $358 |
| Amgen Inc. AMGN | 15 | $230 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $220 |
| Alexion Pharmaceuticals, Inc. AZN | 5 | $197 |
| Pfizer Inc. PFE | 12 | $184 |
| Janssen Biotech, Inc. JNJ | 6 | $179 |
| E.R. Squibb & Sons, L.L.C. BMY | 17 | $144 |
| UCB, Inc. UCB.BR | 6 | $141 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $133 |
| GlaxoSmithKline, LLC. GSK | 4 | $75.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.